Certainly, it's too early to conclude anything yet. Nobody can...

First 41 Last

Share
Profile

Follow
Soul13

519 Posts.

93

14/12/21

16:42

Post #: 58288052
Share

Originally posted by buildabridge: ↑

Hi Soul. I always like to read different views and appreciate them.
I wonder if it is a little early to say if the business has not made the most of Covid to form partnerships?
That may take a little longer to really see.

I would say the next financial results are critical. HIV self-test can now be advertised.
Funding has been announced for telehealth. Joe Hockey and partners will have had a full year to give evidence of his involvement.
The Pacific National trial should have been completed. Box Hill's Febridx trial should have been completed in the next few months.
TGA approval for self-testing should have been complete by Feb.
There really are no excuses after the next financial statement.

You cannot pull a cake out of the oven too quickly. But there definitely comes a time when you say ' tastes not good'.
That time is coming pretty soon.

Expand

Certainly, it's too early to conclude anything yet. Nobody can predict the future, but if you look at it, from the time that COVID began, they basically had two partners, Ng Biotech and Access Bio, both were previous commercial partners.

Atomo has a good product, that's why I'm still interested in the business, it's just they don't seem to deliver enough, maybe is my expectations.

Well, maybe it could change in the future, anyway, all the best.

Last edited by Soul13: 14/12/21

AT1 Price at posting: 16.5¢ Sentiment: None Disclosure: Not Held
5 Upvote

0 Great analysis

Reply